Skip to content
Israel Biotech Fund
  • About
  • Strategy
  • Portfolio
  • Team
  • Advisors
  • Partnerships
  • News
  • Contact
  • Investors
◀︎ All News

Drugging the Undruggable.

January 16th, 2023January 16th, 2023 by Sarit Steinberg

There’s a revolution unfolding in cancer therapeutics as researchers learn to harness the immune system to fight even the most stubborn tumors.

Categories Uncategorized
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market
© 2026 Israel Biotech Fund • Built with GeneratePress